Makan Delrahim, top antitrust official at the Justice Department has pushed back on the testimony his former chief of staff delivered to Congress last week.
Makan Delrahim wrote a letter on Wednesday to the top Democrat and Republican on the House Judiciary Committee. In the letter, Delrahim said John Elias’ testimony was “misleading and lacks critical facts.”
Elias testified that Attorney General William Barr called Antitrust Division leaders to his office for a meeting and then ordered them to scrutinize mergers of marijuana companies because he himself held personal animus toward the industry. Delrahim wrote in his letter, meanwhile, that the division asked for the meeting “for the purpose of resolving significant policy questions at this complex intersection of criminal and civil law enforcement,” reported Politico.
“Notably, the federal antitrust agencies had no prior experience — let alone subject matter expertise — in the cannabis industry,” he wrote.
The letter also addressed Elias’ testimony about the Antitrust Division’s review of an arrangement among auto manufacturers regarding compliance with California’s emissions standards. Elias said the Division leadership directed staff there to start an investigation into the arrangement the day after President Donald Trump wrote on Twitter that he thought it was terrible. Delrahim’s letter, meanwhile, said he first asked staff to analyze the arrangement several weeks before Trump tweeted about it.
Featured News
DOJ and FTC Introduce Website for Reporting Anti-Competitive Healthcare Practices
Apr 18, 2024 by
CPI
US Congress Advances Legislation to Compel TikTok Sale
Apr 18, 2024 by
CPI
UK Financial Sector Advocates Enhanced Regulatory Accountability
Apr 18, 2024 by
CPI
Google and All 50 States Defend $700 Million Consumer Settlement
Apr 18, 2024 by
CPI
Colorado Enacts First Law to Protect Consumer Brainwave Data
Apr 18, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – China Edition – Year of the Dragon
Apr 16, 2024 by
CPI
Review Logic and Rules for Concentrations of Undertakings that Do Not Meet the Standard of Notification
Apr 16, 2024 by
CPI
China’s Review of Semiconductor Transactions
Apr 16, 2024 by
CPI
Key Challenges and Tips for Merger Control Filing in China for Listed Companies
Apr 16, 2024 by
CPI
Key Point Review: China SPC Antitrust Judgments in 2023
Apr 16, 2024 by
CPI